• Advicenne disclosed that Sibnayal is now reimbursed in Spain for distal renal tubular acidosis.
• Reimbursed prices set at EUR 409.84 for the 24 mEq strength, EUR 136.62 for the 8 mEq strength.
• Early access supply in Spain ends with reimbursement; SPA Farma Iberica handles local distribution.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advicenne SA published the original content used to generate this news brief on July 20, 2026, and is solely responsible for the information contained therein.